Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07251725

GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis

Unravelling the Genetic Basis of Familial Pulmonary Fibrosis: A Next-Generation Sequencing Approach to Fibrogenesis and Surfactant Disorder Genes

Status
Recruiting
Phase
Study type
Observational
Enrollment
126 (estimated)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Pulmonary fibrosis (PF) is a progressive lung disease marked by tissue scarring and impaired breathing. Familial pulmonary fibrosis (FPF) makes up 10-20% of PF cases and shares features with idiopathic PF (IPF), but the genetic causes of FPF are not fully understood. This study focuses on uncovering the genetic basis of FPF by analyzing families with multiple affected members. It targets genes involved in fibrogenesis and surfactant disorders, as familial cases often appear earlier and progress more rapidly than sporadic ones. Understanding FPF genetics could: 1. Identify new genetic markers for early diagnosis and prognosis. 2. Improve genetic counseling and preventive strategies for affected families. 3. Reveal therapeutic targets for personalized treatments. 4. Highlight shared molecular pathways between familial and idiopathic PF, potentially benefiting a broader patient group. In summary, the study aims to deepen our understanding of FPF genetics to improve diagnosis, counseling, and treatment for both familial and idiopathic forms of pulmonary fibrosis.

Detailed description

observational study , longitudinal retrospective

Conditions

Timeline

Start date
2025-09-17
Primary completion
2028-09-01
Completion
2028-09-01
First posted
2025-11-26
Last updated
2025-11-26

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07251725. Inclusion in this directory is not an endorsement.